报价延迟最少15分钟:2026/11/05 03:17 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.9125 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
1.69/1.00
|
|
企业价值
51.52M
|
| 资产负债 |
|
每股账面净值
8.88
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
10.30M
|
|
每股收益
0.89
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used byhealthcare providers. |
